Abstract The zoonotic Rift Valley fever virus (RVFV) can cause severe disease in humans
and has pandemic potential, yet no approved vaccine or therapy exists. Here we describe a …

From the beginning of the COVID-19 pandemic, children have exhibited different
susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

The development of SARS-CoV-2 main protease (Mpro) inhibitors for the treatment of
COVID-19 has mostly benefitted from X-ray structures and preexisting knowledge of …

Hantaviruses are high-priority emerging pathogens carried by rodents and transmitted to
humans by aerosolized excreta or, in rare cases, person-to-person contact. While infections …

Rodent-borne hantaviruses are prevalent worldwide and upon spillover to human
populations, cause severe disease for which no specific treatment is available. A potent …

Human parainfluenza virus type 3 (hPIV3) is a respiratory pathogen that can cause severe
disease in older people and infants. Currently, vaccines against hPIV3 are in clinical trials …

Three coronaviruses have spilled over from animal reservoirs into the human population
and caused deadly epidemics or pandemics. The continued emergence of coronaviruses …

The ability of each new SARS-CoV-2 variant to evade host humoral immunity is the focus of
intense research. Each variant may also harbor unique replication capabilities relevant for …

Influenza B viruses (IBVs) comprise a substantial portion of the circulating seasonal human
influenza viruses. Here, we describe the isolation of human monoclonal antibodies (mAbs) …